Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation

D A Blanchard1, M T Affredou, A Vazquez

  • 1INSERM Unit 131-IPSC, Clamart, France.

Insights

Interleukin-4 (IL-4) and anti-IgM antibody together promote B cell proliferation by regulating cyclin D3/cdk6 complex formation and decreasing the p27 inhibitor. This dual action controls cell cycle progression in B cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Interleukin-4 (IL-4) is known to activate B cells and, with co-stimulatory signals, modulate cell cycle progression leading to proliferation.
  • Understanding the molecular mechanisms underlying IL-4-mediated B cell activation and proliferation is crucial for immunology and cancer research.

Purpose of the Study:

  • To investigate the specific molecular events regulated by IL-4 during B cell activation and proliferation.
  • To elucidate the roles of cyclin D3, cyclin-dependent kinase (cdk) 6, and the cdk inhibitor p27kip1 (p27) in IL-4-driven B cell cycle progression.

Main Methods:

  • B cells were stimulated with IL-4 alone, anti-IgM antibody alone, or a combination of IL-4 and anti-IgM antibody.
  • Expression levels of cyclin D3, cdk6, and p27 were analyzed.
  • Cyclin D3/cdk6 complexes were immunoprecipitated and their kinase activity was assessed using recombinant retinoblastoma protein.
  • IL-4's effect on proliferation inhibition in human leukemic B cells was studied in conjunction with p27 expression.

Main Results:

  • The combination of IL-4 and anti-IgM antibody induced cyclin D3 and upregulated cdk6 expression in B cells.
  • A functional cyclin D3/cdk6 complex was formed, capable of phosphorylating retinoblastoma protein.
  • IL-4 or IL-13 alone increased p27 expression, while mitogenic combinations decreased it.
  • IL-4-mediated inhibition of proliferation in leukemic B cells correlated with high p27 levels.

Conclusions:

  • IL-4 controls B cell proliferation through at least two distinct mechanisms.
  • These mechanisms involve the regulation of the cyclin D3/cdk6 complex and the expression of the p27 cdk inhibitor.
  • These findings provide critical insights into the molecular regulation of B cell cycle progression by IL-4.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...